Leicester, United Kingdom

Nigel John Brunskill

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • South Croxton, GB (2020)
  • Leicester, GB (2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Nigel John Brunskill

Introduction

Nigel John Brunskill is a notable inventor based in Leicester, GB. He has made significant contributions to the field of medical science, particularly in the treatment of fibrosis and related conditions. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Brunskill's latest patents focus on methods for inhibiting fibrosis in subjects in need. One aspect of his invention provides methods for treating, inhibiting, alleviating, or preventing fibrosis in mammalian subjects suffering from diseases or disorders caused or exacerbated by fibrosis and inflammation. Specifically, one embodiment addresses renal fibrosis and offers methods to reduce proteinuria in subjects with renal diseases associated with this condition. The methods involve administering a MASP-2 inhibitory agent effective in inhibiting MASP-2-dependent complement activation.

Career Highlights

Throughout his career, Brunskill has worked with esteemed institutions such as the University of Leicester and Omeros Corporation. His research and innovations have garnered attention in the medical community, showcasing his dedication to improving health outcomes.

Collaborations

Brunskill has collaborated with notable professionals in his field, including Gregory A Demopulos and Hans-Wilhelm Schwaeble. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Nigel John Brunskill's contributions to medical science through his innovative patents demonstrate his commitment to addressing critical health issues. His work in inhibiting fibrosis and improving treatment options for renal diseases highlights the importance of research and collaboration in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…